CID 3013402

Schembl4765288

Structural Information

Molecular Formula
C21H20FN5O5S
SMILES
C1CCS(=O)(=O)N(C1)C2=NC(=C(C3=C2C=CC=N3)O)C(=O)NCC4=C(C=C(C=C4)F)C(=O)N
InChI
InChI=1S/C21H20FN5O5S/c22-13-6-5-12(15(10-13)19(23)29)11-25-21(30)17-18(28)16-14(4-3-7-24-16)20(26-17)27-8-1-2-9-33(27,31)32/h3-7,10,28H,1-2,8-9,11H2,(H2,23,29)(H,25,30)
InChIKey
LKPJAAOSOWQREL-UHFFFAOYSA-N
Compound name
N-[(2-carbamoyl-4-fluorophenyl)methyl]-5-(1,1-dioxothiazinan-2-yl)-8-hydroxy-1,6-naphthyridine-7-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

6
Patents

473.1169 Da
Monoisotopic Mass

1.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 474.12418 205.1
[M+Na]+ 496.10612 211.7
[M-H]- 472.10962 208.2
[M+NH4]+ 491.15072 210.0
[M+K]+ 512.08006 205.6
[M+H-H2O]+ 456.11416 194.0
[M+HCOO]- 518.11510 213.1
[M+CH3COO]- 532.13075 236.2
[M+Na-2H]- 494.09157 206.4
[M]+ 473.11635 203.3
[M]- 473.11745 203.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe